The impact of sex, gender and pregnancy on 2009 H1N1 disease

Biology of Sex Differences

Volumn 1, Issue 1, 2010, Pages

  Klein, Sabra L ^a   Passaretti, Catherine ^b   Anker, Martha ^c   Olukoya, Peju ^d   Pekosz, Andrew ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MASSACHUSETTS   (United States)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80052480053     PISSN: None     EISSN: 20426410     Source Type: Journal    
DOI: 10.1186/2042-6410-1-5     Document Type: Review

References (136)

1. Klein SL, Roberts CW, eds: Sex Hormones and Immunity To Infection. Berlin: Springer Verlag; 2010.
2. Anker M, ed: Addressing sex and gender in epidemic-prone infectious diseases. Book Addressing Sex and Gender In Epidemic-Prone Infectious Diseases City: World Health Organization Press; 2007, 1-40.
3. Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, Uyeki TM, Zaki SR, Hayden FG, Hui DS, Kettner JD, Kumar A, Lim M, Shindo N, Penn C, Nicholson KG: Clinical aspects of Pandemic 2009 Influenza A (H1N1) virus infection. N Engl J Med 2010, 362:1708-1719.
4. Centers for Disease Control and dDC: Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 2009, 58:1-8.
5. Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, Lacroix J, Stelfox T, Bagshaw S, Choong K, Lamontagne F, Turgeon AF, Lapinsky S, Ahern SP, Smith O, Siddiqui F, Jouvet P, Khwaja K, McIntyre L, Menon K, Hutchison J, Hornstein D, Joffe A, Lauzier F, Singh J, Karachi T, Wiebe K, Olafson K, Ramsey C, Sharma S, Dodek P, Meade M, Hall R, Fowler RA, Canadian Critical Care Trials Group H1N1 Collaborative: Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 2009, 302:1872-1879.
6. Dominguez-Cherit G, Lapinsky SE, Macias AE, Pinto R, Espinosa-Perez L, de la Torre A, Poblano-Morales M, Baltazar-Torres JA, Bautista E, Martinez A, Martinez MA, Rivero E, Valdez R, Ruiz-Palacios G, Hernández M, Stewart TE, Fowler RA: Critically Ill patients with 2009 influenza A(H1N1) in Mexico. JAMA 2009, 302:1880-1887.
7. Vaillant L, La Ruche G, Tarantola A, Barboza P: Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Euro Surveill 2009, 14:19309.
8. Bermejo-Martin J, Ortiz de Lejarazu R, Pumarola T, Rello J, Almansa R, Ramirez P, Martin-Loeches I, Varillas D, Gallegos M, Seron C, et al: Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. Critical Care 2009, 13:R201.
9. de Castro I, Guzman-Fulgencio M, Garcia-Alvarez M, Resino S: First evidence of a pro-inflammatory response to severe infection with influenza virus H1N1. Critical Care 2010, 14:115.
10. World Health Organization: Women and health: today's evidence tomorrow's agenda. Geneva: WHO; 2009.
11. France AM, Jackson M, Schrag S, Lynch M, Zimmerman C, Biggerstaff M, Hadler J: Household transmission of 2009 influenza A (H1N1) virus after a school-based outbreak in New York City, April-May 2009. J Infect Dis 2010, 201:984-992.
12. World Health Organization: Influenza Pandemic (H1N1) 2009. Republica Argentina. Geneva: WHO; 2009, 1-5.
13. Canadian Ministry of Health: Ontario Novel H1N1 Influenza A Virus Epidemiological Summary. Ontario: Ministry of Health; 2009.
14. Oliveira W, Carmo E, Penna G, Kuchenbecker R, Santos H, Araujo W, Malaguti R, Duncan B, Schmidt M: Pandemic H1N1 influenza in Brazil: analysis of the first 34,506 notified cases of influenza-like illness with severe acute respiratory infection (SARI). Euro Surveill 2009, 14(42):pii 19362.
15. Levy-Bruhl D, Vaux S: Modified surveillance of influenza A(H1N1)v virus infections in France. Euro Surveill 2009, 14(29):pii 19276.
16. Xiao H, Lu SH, Ou Q, Chen YY, Huang SP: Hospitalized patients with novel influenza A (H1N1) virus infection: Shanghai, June-July 2009. Chin Med J (Engl) 2010, 123:401-405.
17. Ling LM, Chow Angela L, Lye David C, Tan Adriana S, Krishnan P, Cui L, Win Nwe N, Chan M, Lim Poh L, Lee Cheng C, Leo YS: Effects of early oseltamivir therapy on viral shedding in 2009 Pandemic Influenza A (H1N1) Virus Infection. Clin Infectious Dis 2010, 50:963-969.
18. Cao B, Li XW, Mao Y, Wang J, Lu HZ, Chen YS, Liang ZA, Liang L, Zhang SJ, Zhang B, Pandemic (H1N1) 2009 Clinical Investigation Group of China, et al: Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med 2009, 361:2507-2517.
19. Belgian Working Group On Influenza A(H1N1)v: Influenza A(H1N1)v virus infections in Belgium, May-June 2009. Euro Surveill 2009, 14(28):pii 19270.
20. Gomez J, Munayco C, Arrasco J, Suarez L, Laguna-Torres V, Aguilar P, Chowell G, Kochel T: Pandemic influenza in a southern hemisphere setting: the experience in Peru from May to September, 2009. Euro Surveill 2009, 14(42):pii 19371.
21. Surveillance Group for New Influenza A(H1N1) Virus Investigation in Italy: Virological surveillance of human cases of influenza A(H1N1)v virus in Italy: preliminary results. Euro Surveill 2009, 14(24):pii 19247.
22. Surveillance Group for New Influenza A(H1N1) Virus Investigation and Control in Spain: New influenza A(H1N1) virus infections in Spain, April-May 2009. Euro Surveill 2009, 14(19):pii 19209.
23. Hahne S, Donker T, Meijer A, Timen A, van Steenbergen J, Osterhaus A, van der Sande M, Koopmans M, Wallinga J, Coutinho R, Dutch New Influenza A (H1N1)v Investigation Team: Epidemiology and control of influenza A (H1N1)v in the Netherlands: the first 115 cases. Euro Surveill 2009, 14(27): pii 19267.
24. de Silva UC, Warachit J, Waicharoen S, Chittaganpitch M: A preliminary analysis of the epidemiology of influenza A(H1N1)v virus infection in Thailand from early outbreak data, June-July 2009. Euro Surveill 2009, 14(31):pii 19292.
25. ECDC working group on influenza A(H1N1)v: Preliminary analysis of influenza A(H1N1)v individual and aggregated case reports from EU and EFTA countries. Euro Surveill 2009, 14(23):19238.
26. Chen KF, Gaydos C, Rothman RE: Update on emerging infections: news from the Centers for Disease Control and Prevention. Hospitalized patients with novel influenza A (H1N1) virus infection-California, April-May, 2009. Ann Emerg Med 2009, 54:732-736.
27. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, Sugerman DE, Druckenmiller JK, Ritger KA, Chugh R, Jasuja S, Deutscher M, Chen S, Walker JD, Duchin JS, Lett S, Soliva S, Wells EV, Swerdlow D, Uyeki TM, Fiore AE, Olsen SJ, Fry AM, Bridges CB, Finelli L, 2009 Pandemic Influenza A (H1N1) Virus Hospitalizations Investigation Team: Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009, 361:1935-1944.
28. CDC: 2009 pandemic influenza A (H1N1) virus infections-Chicago, Illinois, April-July 2009. MMWR Morb Mortal Wkly Rep 2009, 58:913-918.
29. Fleege L, Hallberg E, Morin C, Danila R, Lynfield R: Novel H1N1 influenza hospitalizations: Minneapolis-St. Paul metropolitan area, 2008-2009. Minn Med 2009, 92:38-42.
30. Center for Disease Control: Patients hospitalized with 2009 pandemic influenza A (H1N1)-New York City, May 2009. MMWR Morb Mortal Wkly Rep 2010, 58:1436-1440.
31. Campbell A, Rodin R, Kropp R, Mao Y, Hong Z, Vachon J, Spika J, Pelletier L: Risk of severe outcomes among patients admitted to hospital with pandemic (H1N1) influenza. CMAJ 2010, 182:349-355.
32. van 't Klooster TM, Wielders CC, Donker T, Isken L, Meijer A, van den Wijngaard CC, van der Sande MA, van der Hoek W: Surveillance of hospitalisations for 2009 pandemic influenza A(H1N1) in the Netherlands, 5 June-31 December 2009. Euro Surveill 2010, 15(2):pii 19461.
33. Fielding J, Higgins N, Gregory J, Grant K, Catton M, Bergeri I, Lester R, Kelly H: Pandemic H1N1 influenza surveillance in Victoria, Australia, April-September, 2009. Euro Surveill 2009, 14(42):pii 19368.
34. Tulloch F, Correa R, Guerrero G, Samaniego R, Garcia M, Pascale JM, Martinez A, Mendoza Y, Victoria G, de Lee MN, Marchena L, de Mosca IB, Armien B, Influenza Research Group: Profile of the first cases hospitalized due to influenza A (H1N1) in Panama City, Panama. May-June 2009. J Infect Dev Ctries 2009, 3:811-816.
35. New South Wales public health networke: Progression and impact of the first winter wave of the 2009 pandemic H1N1 influenza in New South Wales, Australia. Euro Surveill 2009, 14(42):pii 19365.
36. Denholm JT, Gordon CL, Johnson PD, Hewagama SS, Stuart RL, Aboltins C, Jeremiah C, Knox J, Lane GP, Tramontana AR, Slavin MA, Schulz TR, Richards M, Birch CJ, Cheng AC: Hospitalised adult patients with pandemic (H1N1) 2009 influenza in Melbourne, Australia. Med J Aust 2010, 192:84-86.
37. ANZIC Influenza Investigators, Webb SA, Pettilä V, Seppelt I, Bellomo R, Bailey M, Cooper DJ, Cretikos M, Davies AR, Finfer S, Harrigan PW, Hart GK, Howe B, Iredell JR, McArthur C, Mitchell I, Morrison S, Nichol AD, Paterson DL, Peake S, Richards B, Stephens D, Turner A, Yung M: Critical Care Services and 2009 H1N1 Influenza in Australia and New Zealand. N Engl J Med 2009, 361:1925-34.
38. Singh AK, Cydulka RK, Stahmer SA, Woodruff PG, Camargo CA Jr: Sex differences among adults presenting to the emergency department with acute asthma. Multicenter Asthma Research Collaboration Investigators. Arch Intern Med 1999, 159:1237-1243. (Pubitemid 29269864)
39. Schatz M, Clark S, Camargo CA Jr: Sex differences in the presentation and course of asthma hospitalizations. Chest 2006, 129:50-55. (Pubitemid 43265242)
40. Moorman JE, Rudd RA, Johnson CA, King M, Minor P, Bailey C, Scalia MR, Akinbami LJ, Centers for Disease C, Prevention: National surveillance for asthma-United States, 1980-2004. MMWR Surveillance Summaries 2007, 56:1-54.
41. Archer B, Cohen C, Naidoo D, Thomas J, Makunga C, Blumberg L, Venter M, Timothy G, Puren A, McAnerney J, et al: Interim report on pandemic H1N1 influenza virus infections in South Africa, April to October 2009: epidemiology and factors associated with fatal cases. Euro Surveill 2009, 14(42):pii 19369.
42. Rasmussen SA, Jamieson DJ, Bresee JS: Pandemic influenza and pregnant women. Emerg Infect Dis 2008, 14:95-100.
43. Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, Vugia D, Harriman K, Matyas B, Glaser CA, California Pandemic (H1N1) Working Group, et al: Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 2009, 302:1896-1902.
44. Echevarría-Zuno S, Mejía-Aranguré JM, Mar-Obeso AJ, Grajales-Muñiz C, Robles-Pérez E, González-León M, Ortega-Alvarez MC, Gonzalez-Bonilla C, Rascón-Pacheco RA, Borja-Aburto VH: Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis. Lancet 2009, 374:2072-2079.
45. CDC: Novel influenza A (H1N1) virus infections in three pregnant women-United States, April-May 2009. MMWR Morb Mortal Wkly Rep 2009, 58:497-500.
46. Hewagama S, Walker Sue P, Stuart Rhonda L, Gordon C, Johnson Paul DR, Friedman ND, O'Reilly M, Cheng Allen C, Giles Michelle L: 2009 H1N1 Influenza A and Pregnancy Outcomes in Victoria, Australia. Clinical Infectious Diseases 2010, 50:686-690.
47. Lim ML, Chong CY, Tee WSN, Lim WY, Chee JJ: Influenza A/H1N1 (2009) infection in pregnancy; an Asian perspective. BJOG Int J Obstet Gynaecol 2010, 117(5):551-6.
48. Siston AM, Rasmussen SA, Honein MA, Fry AM, Seib K, Callaghan WM, Louie J, Doyle TJ, Crockett M, Lynfield R, Moore Z, Wiedeman C, Anand M, Tabony L, Nielsen CF, Waller K, Page S, Thompson JM, Avery C, Springs CB, Jones T, Williams JL, Newsome K, Finelli L, Jamieson DJ, Pandemic H1N1 Influenza in Pregnancy Working Group: Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA 2010, 303:1517-1525.
49. Creanga AA, Johnson TF, Graitcer SB, Hartman LK, Al-Samarrai T, Schwarz AG, Chu SY, Sackoff JE, Jamieson DJ, Fine AD, Shapiro-Mendoza CK, Jones LE, Uyeki TM, Balter S, Bish CL, Finelli L, Honein MA: Severity of 2009 pandemic influenza A (H1N1) virus infection in pregnant women. Obstet Gynecol 2010, 115:717-726.
50. Louie JK, Acosta M, Jamieson DJ, Honein MA, the California Pandemic Working G: Severe 2009 H1N1 Influenza in Pregnant and Postpartum Women in California. N Engl J Med 2010, 362:27-35.
51. Jamieson DJ, Honein MA, Rasmussen SA, Williams JL, Swerdlow DL, Biggerstaff MS, Lindstrom S, Louie JK, Christ CM, Bohm SR, Fonseca VP, Ritger KA, Kuhles DJ, Eggers P, Bruce H, Davidson HA, Lutterloh E, Harris ML, Burke C, Cocoros N, Finelli L, MacFarlane KF, Shu B, Olsen SJ, Novel Influenza A (H1N1) Pregnancy Working Group: H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009, 374:451-458.
52. Lapinsky SE: H1N1 novel influenza A in pregnant and immunocompromised patients. Crit Care Med 2010, 38:e52-e57.
53. CDC: 2009 Pandemic Influenza A (H1N1) in Pregnant Women Requiring Intensive Care-New York City, 2009. Morb Mortal Wkly Rep 2010, 59:321-326.
54. Fiore AE, Shay DK, Broder K, Iskander JK, Uyeki TM, Mootrey G, Bresee JS, Cox NJ: Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 2009, 58:1-52.
55. Bridges CB, Kuehnert MJ, Hall CB: Transmission of influenza: implications for control in health care settings. Clinical Infect Dis 2003, 37:1094-1101. (Pubitemid 37323665)
56. Sax H, Uckay I, Richet H, Allegranzi B, Pittet D: Determinants of good adherence to hand hygiene among healthcare workers who have extensive exposure to hand hygiene campaigns. Infect Control Hosp Epidemiol 2007, 28:1267-1274. (Pubitemid 47596566)
57. Daugherty EL, Perl TM, Needham DM, Rubinson L, Bilderback A, Rand CS: The use of personal protective equipment for control of influenza among critical care clinicians: A survey study. Crit Care Med 2009, 37:1210-1216.
58. Ojanuga DN, Gilbert C: Women's access to health care in developing countries. Social Sci Med 1992, 35:613-617. (Pubitemid 23364852)
59. Kamate SK, Agrawal A, Chaudhary H, Singh K, Mishra P, Asawa K: Public knowledge, attitude and behavioural changes in an Indian population during the Influenza A (H1N1) outbreak. J Infection Dev Countries 2010, 4:7-14.
60. CDC: Safety of influenza A (H1N1) 2009 monovalent vaccines-United States, October 1-November 24, 2009. Morb Mortal Wkly Rep 2009, 58:1351-1356.
61. O'Riordan S, Barton M, Yau Y, Read SE, Allen U, Tran D: Risk factors and outcomes among children admitted to hospital with pandemic H1N1 influenza. CMAJ 2010, 182:39-44.
62. McCallister JW, Mastronarde JG: Sex differences in asthma. J Asthm 2008, 45:853-861.
63. Kwon HL, Triche EW, Belanger K, Bracken MB: The epidemiology of asthma during pregnancy: prevalence, diagnosis, and symptoms. Immunol Allergy Clin North Am 2006, 26:29-62. (Pubitemid 43144610)
64. Nick JA, Chacon CS, Brayshaw SJ, Jones MC, Barboa CM, St Clair CG, Young RL, Nichols DP, Janssen JS, Huitt GA, Iseman MD, Daley CL, Taylor-Cousar JL, Accurso FJ, Saavedra MT, Sontag MK: Effects of gender and age of diagnosis on disease progression in long-term cystic fibrosis survivors. Am J Respir Crit Care Med 2010.
65. de Torres JP, Cote CG, Lopez MV, Casanova C, Diaz O, Marin JM, Pinto-Plata V, de Oca MM, Nekach H, Dordelly LJ, Aguirre-Jaime A, Celli BR: Sex differences in mortality in patients with COPD. Eur Respir J 2009, 33:528-535.
66. Langhammer A, Johnsen R, Gulsvik A, Holmen TL, Bjermer L: Sex differences in lung vulnerability to tobacco smoking. Eur Respir J 2003, 21:1017-1023. (Pubitemid 36675620)
67. El-Serag HB, Rudolph KL: Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007, 132:2557-2576. (Pubitemid 46890874)
68. Tsay PK, Tai DI, Chen YM, Yu CP, Wan SY, Shen YJ, Lin DY: Impact of gender, viral transmission and aging in the prevalence of hepatitis B surface antigen. Chang Gung Med J 2009, 32:155-164.
69. Wang SH, Yeh SH, Lin WH, Wang HY, Chen DS, Chen PJ: Identification of androgen response elements in the enhancer I of hepatitis B virus: a mechanism for sex disparity in chronic hepatitis B. Hepatology 2009, 50:1392-1402.
70. Bellentani S, Scaglioni F, Marino M, Bedogni G: Epidemiology of nonalcoholic fatty liver disease. Dig Dis 2010, 28:155-161.
71. Hochman JS, Tamis JE, Thompson TD, Weaver WD, White HD, Van de Werf F, Aylward P, Topol EJ, Califf RM: Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators. New Engl J Med 1999, 341:226-232.
72. Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF: Lifetime risk for diabetes mellitus in the United States. JAMA 2003, 290:1884-1890. (Pubitemid 37430605)
73. Zeitler P: Update on nonautoimmune diabetes in children. J Clin Endocrinol Metabolism 2009, 94:2215-2220.
74. Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, Wapner RJ, Varner MW, Rouse DJ, Thorp JM Jr, Sciscione A, Catalano P, Harper M, Saade G, Lain KY, Sorokin Y, Peaceman AM, Tolosa JE, Anderson GB, Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network: A multicenter, randomized trial of treatment for mild gestational diabetes. New Engl J Med 2009, 361:1339-1348.
75. Schneiderman EH: Gestational Diabetes: an Overview of a Growing Health Concern for Women. J Infusion Nursing 2010, 33:48-54, 10.1097/NAN. 1090b1013e3181c1096d1983.
76. Correa-de-Araujo R, McDermott K, Moy E: Gender differences across racial and ethnic groups in the quality of care for diabetes. Women's Health Issues 2006, 16:56-65.
77. Low S, Chin MC, Deurenberg-Yap M: Review on epidemic of obesity. Annals Acad Med Singapore 2009, 38:57-59.
78. Case A, Menendez A: Sex differences in obesity rates in poor countries: Evidence from South Africa. Economics Human Biol 2009, 7:271-282.
79. Fattah C, Farah N, Barry S, O'Connor N, Stuart B, Turner MJ: The measurement of maternal adiposity. J Obstet Gynaecol 2009, 29:686-689.
80. Klein NC, Chak A, Chengot M, Johnson DH, Cunha BA: Fatal case of pneumonia associated with pandemic (H1N1) 2009 in HIV-positive patient. Emerg Infect Dis 2010, 16:149-150.
81. Quinn TC, Overbaugh J: HIV/AIDS in women: an expanding epidemic. Science 2005, 308:1582-1583. (Pubitemid 40807496)
82. Napravnik S, Poole C, Thomas JC, Eron JJ Jr: Gender difference in HIV RNA levels: a meta-analysis of published studies. J Acquir Immune Defic Syndr 2002, 31:11-19.
83. Meier A, Chang JJ, Chan ES, Pollard RB, Sidhu HK, Kulkarni S, Wen TF, Lindsay RJ, Orellana L, Mildvan D, et al: Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. Nat Med 2009, 15:955-959.
84. Siddiqui RA, Sauermann U, Altmuller J, Fritzer E, Nothnagel M, Dalibor N, Fellay J, Kaup FJ, Stahl-Hennig C, Nurnberg P, Krawczak M, Platzer M: X chromosomal variation is associated with slow progression to AIDS in HIV-1-infected women. Am J Hum Genet 2009, 85:228-239.
85. Chakrapani V, Newman PA, Shunmugam M, Kurian AK, Dubrow R: Barriers to Free Antiretroviral Treatment Access for Female Sex Workers in Chennai, India. AIDS Patient Care STDs 2009, 23:973-980.
86. Remien RH, Chowdhury J, Mokhbat JE, Soliman C, Adawy ME, El-Sadr W: Gender and care: access to HIV testing, care, and treatment. J Acqu Immune Deficiency Syndromes 2009, 51(Suppl 3):S106-S110.
87. Greenberg ME, Lai MH, Hartel GF, Wichems CH, Gittleson C, Bennet J, Dawson G, Hu W, Leggio C, Washington D, Basser RL: Response to a monovalent 2009 influenza A (H1N1) vaccine. N Engl J Med 2009, 361:2405-2413.
88. Clark TW, Pareek M, Hoschler K, Dillon H, Nicholson KG, Groth N, Stephenson I: Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. N Engl J Med 2009, 361:2424-2435.
89. Roman F, Vaman T, Gerlach B, Markendorf A, Gillard P, Devaster JM: Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: preliminary report of an observer-blind, randomised trial. Vaccine 2010, 28:1740-1745.
90. Nolan T, McVernon J, Skeljo M, Richmond P, Wadia U, Lambert S, Nissen M, Marshall H, Booy R, Heron L, Hartel G, Lai M, Basser R, Gittleson C, Greenberg M: Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial. JAMA 2010, 303:37-46.
91. CDC: Interim results: influenza A (H1N1) 2009 monovalent vaccination coverage-United States, October-December 2009. Morb Mortal Wkly Rep 2010, 59:44-48.
92. Endrich MM, Blank PR, Szucs TD: Influenza vaccination uptake and socioeconomic determinants in 11 European countries. Vaccine 2009, 27:4018-4024.
93. Opstelten W, van Essen GA, Ballieux MJ, Goudswaard AN: Influenza immunization of Dutch general practitioners: vaccination rate and attitudes towards vaccination. Vaccine 2008, 26:5918-5921.
94. Merrill RM, Beard JD: Influenza vaccination in the United States, 2005-2007. Med Sci Monit 2009, 15:PH92-PH100.
95. Santibanez TA, Mootrey GT, Euler GL, Janssen AP: Behavior and beliefs about influenza vaccine among adults aged 50-64 years. Am J Health Behav 2010, 34:77-89.
96. Chor JS, Ngai KL, Goggins WB, Wong MC, Wong SY, Lee N, Leung TF, Rainer TH, Griffiths S, Chan PK: Willingness of Hong Kong healthcare workers to accept pre-pandemic influenza vaccination at different WHO alert levels: two questionnaire surveys. BMJ 2009, 339:b3391.
97. Schwarzinger M, Flicoteaux R, Cortarenoda S, Obadia Y, Moatti JP: Low acceptability of A/H1N1 pandemic vaccination in French adult population: did public health policy fuel public dissonance? PLoS One 2010, 5:e10199.
98. WHO: Influenza Vaccines: WHO position paper. Wkly Epidemiological Record 2005, 80:277-288.
99. WHO: Strategic Advisory Group of Experts on Immunization-report of the extraordinary meeting on the influenza A (H1N1) 2009 pandemic, 7 July 2009. Wkly Epidemiol Rec 2009, 84:301-304.
100. Keitel WA, Atmar RL, Cate TR, Petersen NJ, Greenberg SB, Ruben F, Couch RB: Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons. Arch Intern Med 2006, 166:1121-1127. (Pubitemid 43765184)
101. Cook IF: Sexual dimorphism of humoral immunity with human vaccines. Vaccine 2008, 26:3551-3555.
102. Engler RJ, Nelson MR, Klote MM, Van Raden MJ, Huang CY, Cox NJ, Klimov A, Keitel WA, Nichol KL, Carr WW, Treanor JJ: Half-vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses. Arch Intern Med 2008, 168:2405-2414.
103. Cook IF, Barr I, Hartel G, Pond D, Hampson AW: Reactogenicity and immunogenicity of an inactivated influenza vaccine administered by intramuscular or subcutaneous injection in elderly adults. Vaccine 2006, 24:2395-2402. (Pubitemid 43290422)
104. Jackson LA, Austin G, Chen RT, Stout R, DeStefano F, Gorse GJ, Newman FK, Yu O, Weniger BG: Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors. Vaccine 2001, 19:4703-4709. (Pubitemid 32800754)
105. NIAID:[http://www.niaid.nih.gov/news/newsreleases/2009/Pages/ H1N1pregnantresults.aspx].
106. Beyer WE, Palache AM, Kerstens R, Masurel N: Gender differences in local and systemic reactions to inactivated influenza vaccine, established by a meta-analysis of fourteen independent studies. Eur J Clin Microbiol Infect Dis 1996, 15:65-70. (Pubitemid 26051264)
107. Nichol KL, Margolis KL, Lind A, Murdoch M, McFadden R, Hauge M, Magnan S, Drake M: Side effects associated with influenza vaccination in healthy working adults. A randomized, placebo-controlled trial. Arch Intern Med 1996, 156:1546-1550.
108. Robb H, Fausone CA, Rudy DR, McArthur S: Side effects from influenza vaccination: differences between returned and random surveys. Mil Med 1996, 161:29-32. (Pubitemid 26035349)
109. Pittman PR: Aluminum-containing vaccine associated adverse events: role of route of administration and gender. Vaccine 2002, 20(Suppl 3): S48-S50. (Pubitemid 34607676)
110. Skowronski DM, De Serres G: Is routine influenza immunization warranted in early pregnancy? Vaccine 2009, 27:4754-4770.
111. Englund JA: Maternal immunization with inactivated influenza vaccine: rationale and experience. Vaccine 2003, 21:3460-3464. (Pubitemid 36792103)
112. Tsai T, Kyaw MH, Novicki D, Nacci P, Rai S, Clemens R: Exposure to MF59-adjuvanted influenza vaccines during pregnancy-A retrospective analysis. Vaccine 2010, 28:1877-1880.
113. Casscells SW, Granger E, Kress AM, Linton A: The association between oseltamivir use and adverse neuropsychiatric outcomes among TRICARE beneficiaries, ages 1 through 21 years diagnosed with influenza. Int J Adolesc Med Health 2009, 21:79-89.
114. Linder JA, Bates DW, Platt R: Antivirals and antibiotics for influenza in the United States, 1995-2002. Pharmacoepidemiol Drug Saf 2005, 14:531-536. (Pubitemid 41179481)
115. Leon K, McDonald MC, Moore B, Rust G: Disparities in Influenza Treatment Among Disabled Medicaid Patients in Georgia. Am J Public Health 2009, 99(Suppl 2):S378-S382.
116. Bettis R, Iacuzio D, Jung T, Fuchs R, Aultman R, Gyldmark M: Impact of influenza treatment with oseltamivir on health, sleep and daily activities of otherwise healthy adults and adolescents. Clin Drug Investig 2006, 26:329-340. (Pubitemid 43876567)
117. Fish EN: The X-files in immunity: sex-based differences predispose immune responses. Nat Rev Immunol 2008, 8:737-744.
118. Klein SL, Huber S: Sex differences in susceptibility to viral infection. In Sex Hormones and Immunity to Infection. Edited by: Klein SL, Roberts CW. Berlin: Springer-Verlag; 2010.
119. Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, Huang GT, Iloeje UH: Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006, 295:65-73. (Pubitemid 43042691)
120. Yu MW, Cheng SW, Lin MW, Yang SY, Liaw YF, Chang HC, Hsiao TJ, Lin SM, Lee SD, Chen PJ, Liu CJ, Chen CJ: Androgen-receptor gene CAG repeats, plasma testosterone levels, and risk of hepatitis B-related hepatocellular carcinoma. J Natl Cancer Inst 2000, 92:2023-2028.
121. Yu MW, Yang YC, Yang SY, Cheng SW, Liaw YF, Lin SM, Chen CJ: Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: a nested case-control study among men. J Natl Cancer Inst 2001, 93:1644-1651.
122. Farza H, Salmon AM, Hadchouel M, Moreau JL, Babinet C, Tiollais P, Pourcel C: Hepatitis B surface antigen gene expression is regulated by sex steroids and glucocorticoids in transgenic mice. Proc Natl Acad Sci USA 1987, 84:1187-1191. (Pubitemid 17027317)
123. Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM, Karin M: Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 2007, 317:121-124. (Pubitemid 47056470)
124. Roberts CW, Walker W, Alexander J: Sex-associated hormones and immunity to protozoan parasites. Clin Microbiol Rev 2001, 14:476-488. (Pubitemid 32642746)
125. McKay LI, Cidlowski JA: Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways. Endocr Rev 1999, 20:435-459. (Pubitemid 30648895)
126. Straub RH: The complex role of estrogens in inflammation. Endocr Rev 2007, 28:521-574. (Pubitemid 47236336)
127. Liu HB, Loo KK, Palaszynski K, Ashouri J, Lubahn DB, Voskuhl RR: Estrogen receptor alpha mediates estrogen's immune protection in autoimmune disease. J Immunol 2003, 171:6936-6940. (Pubitemid 37532130)
128. Soldan SS, Alvarez Retuerto AI, Sicotte NL, Voskuhl RR: Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol. J Immunol 2003, 171:6267-6274. (Pubitemid 37467250)
129. Miller L, Hunt JS: Sex steroid hormones and macrophage function. Life Sci 1996, 59:1-14. (Pubitemid 26198120)
130. Piccinni MP, Giudizi MG, Biagiotti R, Beloni L, Giannarini L, Sampognaro S, Parronchi P, Manetti R, Annunziato F, Livi C, et al: Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J Immunol 1995, 155:128-133.
131. Piccinni MP, Scaletti C, Maggi E, Romagnani S: Role of hormone-controlled Th1-and Th2-type cytokines in successful pregnancy. J Neuroimmunol 2000, 109:30-33.
132. Lu FX, Abel K, Ma Z, Rourke T, Lu D, Torten J, McChesney M, Miller CJ: The strength of B cell immunity in female rhesus macaques is controlled by CD8+ T cells under the influence of ovarian steroid hormones. Clin Exp Immunol 2002, 128:10-20. (Pubitemid 34451174)
133. Gordon CL, Johnson PD, Permezel M, Holmes NE, Gutteridge G, McDonald CF, Eisen DP, Stewardson AJ, Edington J, Charles PG, Crinis N, Black MJ, Torresi J, Grayson ML: Association between Severe Pandemic 2009 Influenza A (H1N1) Virus Infection and Immunoglobulin G2 Subclass Deficiency. Clin Infect Dis 2010, 50:672-678.
134. Estenssoro E, Rios FG, Apezteguia C, Reina R, Neira J, Ceraso DH, Orlandi C, Valentini R, Tiribelli N, Brizuela M, Registry of the Argentinian Society of Intensive Care SATI, et al: Pandemic 2009 Influenza A(H1N1) in Argentina: a study of 337 patients on mechanical ventilation. Am J Respir Crit Care Med 2010, 182:41-48.
135. Riquelme R, Riquelme M, Rioseco ML, Inzunza C, Gomez Y, Contreras C, Riquelme J, Peyrani P, Wiemken T, Ramirez J: Characteristics of hospitalized patients with 2009 H1N1 influenza in Chile. Eur Respir J 2010.
136. Fuhrman C, Bonmarin I, Paty AC, Duport N, Chiron E, Lucas E, Bitar D, Mailles A, Herida M, Vaux S, et al: Severe hospitalised 2009 pandemic influenza A(H1N1) cases in France, 1 July-15 November 2009. Euro Surveill 2010, 15(2):pii 19463.